7 Articles found
Regeneus Ltd. Articles
-
Q&A with Flyn McKinnirey, R&D Manager at Regeneus
Q. What is your background and experience in the regenerative medicine and stem cell space? How did this lead you to Regeneus? A. I’d always had a love for medical research, however found myself working in the pharmaceutical industry after ...
-
Q&A with Dr. Cindy Shu, REDI Fellow
After being awarded the MTPConnect REDI Fellowship Grant in August 2020, Postdoctoral Research Fellow from the Kolling Institute and University of Sydney Royal North Shore Hospital, Dr. Cindy Shu is joining Regeneus for a 12-month project focused on ...
-
Q&A with Chrys Maoudis, Research Scientist at Regeneus
Q. What is your background and experience in the regenerative medicine and stem cell space? How did this lead you to Regeneus? A. I have always had a passion to play a part in improving people’s health and this passion led me to ...
-
Q&A with Brian Saputro, R&D Scientist at Regeneus
Q. How did you develop your interest in the regenerative medicine and stem cell space? A. Born and raised in Indonesia, where the curriculum was quite focused on science, I have always been intrigued in life sciences and everything related. I came ...
-
Q&A with Dr. Veronica Iatarola Antas, Research Scientist and Project Lead at Regeneus
Q. Tell us about your role as a Research Scientist and Project Lead at Regeneus? A. My role is extremely diverse and has evolved over my time at Regeneus. Initially, I was responsible for optimising our product manufacturing processes, ...
-
Q&A with Prof. Graham Vesey PhD, Chief Scientific Officer and Executive Director at Regeneus
Q. Tell us about your role as Chief Scientific Officer at Regeneus? A. My role at Regeneus from the beginning has been to invent and develop Regeneus’ intellectual property (IP). With over 30 years’ experience as a scientific ...
-
Regeneus partners with Australian Department of Defence to develop Sygenus for combat casualty care
Regeneus is excited to announce it is partnering with the Australian Department of Defence to develop its platform stem cell bioactive secretome technology Sygenus for combat casualty care. As part of the grant, Regeneus will receive $300k in ...